Harrisson S et al. Six month interim results of MSDC-0602K in a large phase 2b NASH study demonstrate significant improvement in liver enzymes and glycemic control (NCT02784444). (Abstract PS-111)
ICS verlagen SARS-CoV-2-gerelateerde genen bij COPD
nov 2021 | COPD, Virale infecties